| Literature DB >> 25812013 |
Lucie Blok1, Suvanand Sahu2, Jacob Creswell2, Sandra Alba3, Robert Stevens4, Mirjam I Bakker3.
Abstract
BACKGROUND: Screening of household contacts of tuberculosis (TB) patients is a recommended strategy to improve early case detection. While it has been widely implemented in low prevalence countries, the most optimal protocols for contact investigation in high prevalence, low resource settings is yet to be determined. This study evaluated contact investigation interventions in eleven lower and middle income countries and reviewed the association between context or program-related factors and the yield of cases among contacts.Entities:
Mesh:
Year: 2015 PMID: 25812013 PMCID: PMC4374904 DOI: 10.1371/journal.pone.0119822
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Process Indicators in Contact Investigation.
Fig 2Screening for Study Inclusion Flowchart.
Description of intervention setting, screening approaches and definitions.
| Project | Setting | Profile | Index | type | Test | Diagnostic test | Screening | Screening | Incentives & | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TB | MDR | HIV | criteria | location | by whom | enablers | ||||||
| Afghanistan-1 | Rural | 358 | 3.5% | <0.1% | SS+ | no child | TC-1 | SSM | Home-ST | CHW | PBI | |
| Afghanistan-2 | Rural | 358 | 3.5% | <0.1% | SS+ | incl. child | TC-1 | SSM | CXR | Home-ST | CHW | PBI |
| DRC-1 | Rural | 576 | 2.5% | 1.1% | SS+ | incl. child | TC-1 | SSM | Home-ref / MT | HW | None | |
| DRC-2 | Rural | 576 | 2.5% | 1.1% | Incl. other | incl. child | TC-2 | SSM | CXR | Home-ST | CHW | PBI for screen, transport, diagnosis |
| DRC-3 | Rural | 576 | 2.5% | 1.1% | Incl. other | incl. child | TC-2 | SSM | CXR | Home-ST | CHW | PBI for screen, transport, diagnosis |
| DRC-4 | Rural | 576 | 2.5% | 1.1% | Incl. other | incl. child | TC-2 | SSM | CXR | Home-ST | CHW | PBI for screen, transport, diagnosis |
| Ethiopia-1 | Rural | 224 | 1.6% | 1.3% | SS+ | incl. child | TC-1 | SSM | Home-ref | HEWvolunteers | No | |
| Ethiopia-2 | Rural | 224 | 1.6% | 1.3% | SS+ | incl. child | TC-1 | SSM (few LED-FM) | CXR | Home-ST | HEW/ volunteers | PBI in form of air time for staff |
| Kenya-1 | Mixed | 299 | 2.5% | 6.1% | SS+ | no child | TC-1 | SSM | CXR | Home-ST /-ref | CHW | Bus fare & lunch allowance plus PBI |
| Kenya-2 | Urban | 299 | 2.5% | 6.1% | SS+ | incl. child | TC-2 | SSM | Home-ref | CHW | Small in kind support | |
| Lao rep | Rural | 514 | 4.9% | 0.3% | SS+ | no child | TC-2 | SSM | Home-ST | CHW | Monetary incentives TB manager | |
| Nepal | Mixed | 241 | 2.3% | 0.3% | SS+ | incl. child | TC-2 | SSM | Home-ST | NGOstaff | None | |
| Nigeria | Rural | 161 | 2.9% | 3.1% | SS+ | no child | TC-2 | SSM | Home-ref | CHW | PBI | |
| Pakistan-1 | Mixed | 376 | 3.5% | <0.1% | SS+ | incl. child | TC-2 | SSM | Home-ref | SW | PBI accompanied referral | |
| Pakistan-2 | Urban | 376 | 3.5% | <0.1% | Incl. other | incl. child | TC-2 | SSM | CXR | Home-ref | CHW | |
| Uganda-1 | Rural | 175 | 1.4% | 7.2% | SS+ | incl. child | TC-3 | SSM | Home-ST | CHW/HW | Monetary incentive MoH-HW | |
| Uganda-2 | Rural | 175 | 1.4% | 7.2% | SS+ | incl. child | TC-3 | SSM | Home-ST | volunteer | PBI | |
| Yemen | Mixed | 70 | 1.7% | 0.1% | SS+ | incl. child | TC-3 | LED-FM (culture) | Home-ST / invite | CHW | Transport refund contacts | |
| Zimbabwe | Urban | 433 | 1.9% | 14.7% | SS+ | incl. child | TC-2 | SSM | CXR | Home-ref | HW | None |
* WHO 2012: TB data[1] presented as cases per 100,000 pop/year; MDR = multi drug resistance (%) among newly diagnosed TB cases[1]; HIV prevalence(%) among adults aged 15–49 years[14]
† SS+ = smear positive only; ‘incl. other’ = includes SS- pulmonary and/or extra-pulmonary TB; ‘incl. child = children included as index case; ‘no child’ = no children as index case.
‡ TC-1 = Cough ≥ 2weeks with or without other symptoms; TC-2 = Any (or combination) out of five to seven TB related symptoms; TC-3 = All contacts irrespective of symptoms
§ SSM = Standard sputum smear microscopy; LED-FM = Light emission diode fluorescent microscopy; CXR = Chest X-ray
| Home-ref = screening at household followed by referral of suspects for testing; Home-ST = Screening and sputum collected at home and transported for testing; Invite = contacts are invited to present at facility for screening, MT = Mobile team outreach to community for screening and testing.
¶ HW = health staff in clinic or through outreach; HEW = health extension worker; CHW = community health worker; SW = social worker
** PBI = performance based monetary incentives
Number of people screened and number of smear positive (SM+) and all forms of TB identified through contact investigation in 19 projects.
| Project | Contacts screened | SS+ | % SS+/screen | 95% CI | NNS (SS+) | All TB | % All TB/screen | 95% CI | NNS (All TB) |
|---|---|---|---|---|---|---|---|---|---|
| Afghanistan-1 | 7232 | 136 | 1.9% | (1.6–2.2%) | 53 | ||||
| Afghanistan-2 | 19383 | 210 | 1.1% | (0.9–1.2%) | 92 | 307 | 1.6% | (1.4–1.8%) | 63 |
| DRC-1 | 5814 | 166 | 2.9% | (2.4–3.3%) | 35 | ||||
| DRC-2 | 18384 | 322 | 1.8% | (1.6–1.9%) | 57 | 397 | 2.2% | (1.9–2.4%) | 46 |
| DRC-3 | 16552 | 300 | 1.8% | (1.6–2.0%) | 55 | 464 | 2.8% | (2.6–3.1%) | 36 |
| DRC-4 | 13265 | 127 | 1.0% | (0.8–1.1%) | 104 | 178 | 1.3% | (1.1–1.5%) | 75 |
| Ethiopia-1 | 490 | 11 | 2.2% | (0.9–3.6%) | 45 | ||||
| Ethiopia-2 | 8005 | 62 | 0.8% | (0.6–1.0%) | 129 | 69 | 0.9% | (0.7–1.1%) | 116 |
| Kenya-1 | 742 | 3 | 0.4% | (0.0–0.9%) | 247 | ||||
| Kenya-2 | 6274 | 87 | 1.4% | (1.1–1.7%) | 72 | 133 | 2.1% | (1.8–2.5%) | 47 |
| Lao rep | 316 | 1 | 0.3% | (0.0–0.9%) | 316 | ||||
| Nepal | 6596 | 68 | 1.0% | (0.8–1.3%) | 97 | ||||
| Nigeria | 387 | 9 | 2.3% | (0.8–3.8%) | 43 | ||||
| Pakistan-1 | 19191 | 490 | 2.6% | (2.3–2.7%) | 39 | 538 | 2.8% | (2.5–3.0%) | 36 |
| Pakistan-2 | 3111 | 4 | 0.1% | (0.0–0.3%) | 778 | 19 | 0.6% | (0.3–0.9%) | 164 |
| Uganda-1 | 4638 | 287 | 6.2% | (5.5–6.9%) | 16 | ||||
| Uganda-2 | 573 | 32 | 5.6% | (3.7–7.5%) | 18 | ||||
| Yemen | 3200 | 123 | 3.8% | (3.2–4.5%) | 26 | 152 | 4.8% | (4.0–5.5%) | 21 |
| Zimbabwe | 4899 | 60 | 1.2% | (0.9–1.5%) | 82 | ||||
| Total | 139052 | 2498 | 2257 | ||||||
| Pooled % yield: | 1.5% | (1.0–2.2%) | 67 (45–100) | 1.8% | (1.2–2.7%) | 56(37–83) | |||
*Confidence intervals were derived through a Wilson score interval method
Fig 3Forest plot of the proportion SS+TB among screened household contacts of TB patients.
Fig 4Forest plot of the proportion of any form of TB among screened household contacts of TB patients.
Association between program design or contextual factors and the percentage yield of contact tracing using random effect, exact binomial logistic regression.
| Univariate models (complete case analysis) | Multi variate model (N = 19) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| N projects | N screened | OR | (95% CI) | p-value | aOR | (95% CI) | p-value | ||
|
| |||||||||
|
| |||||||||
| - Index includes children | Reference | 15 | 8677 | 1 | dropped in backward elimination | ||||
| - Index does not include children | 4 | 130375 | 0.59 | (0.22–1.64) | 0.317 | ||||
| - SS+ index cases only | Reference | 15 | 87740 | 1 | 1 | ||||
| - SS+ and (SS- and/or EPTB) index cases | 4 | 51312 | 0.49 | (0.20–1.20) | 0.119 |
|
|
| |
|
| 19 | 139052 | 0.005 |
| |||||
| - Contact with cough at least 2 weeks | Reference | 6 | 41666 | 1 | 1 | ||||
| - Contact with any TB related symptoms | 10 | 88975 | 0.87 | (0.47–1.62) | 0.663 | 1.71 | (0.94–3.13) | 0.080 | |
| - Any HH contact irrespective of symptoms | 3 | 8411 |
|
|
|
|
|
| |
|
| 7 | 63090 | 0.72 | (0.50–1.04) | 0.080 | not included in multivariate analysis ( | |||
|
| 14 | 118533 | 0.77 | (0.57–1.06) | 0.109 | not included in multivariate analysis ( | |||
|
| 7 | 63090 | 0.79 | (0.50–1.23) | 0.293 | not included in multivariate analysis ( | |||
|
| |||||||||
|
| 19 | 139052 | 0.84 | (0.67–1.07) | 0.160 | 1.22 | (0.99–1.50) | 0.057 | |
|
| |||||||||
| Rural | Reference | 12 | 95039 | 1 | 1 | ||||
| Urban/mixed | 7 | 44013 | 0.58 | (0.27–1.27) | 0.175 |
|
|
| |
*The Odds ratio compares the chance of confirming contacts as being a SS+ case in different program designs and context settings
† Wald test of significance of effect; LLR test of significance of variable in the model
‡ variable could not be included in multivariate analysis due to unavailability of data for several projects
§ Coverage of contacts defined as percentage of identified contacts that enter screening algorithm
Coverage of contact screening (n = 15).
| Index cases | contacts | symptomatic | Full | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Project | Eligible | CI | % coverage | Iden-tified | Verbal screened | % coverage | Number | Tested (sputum) | % coverage | screening identified contacts |
| Afghanistan-2 | 4447 | 2894 | 65.1% | 19383 | 6782 | |||||
| DRC-2 | 6773 | 4528 | 66.9% | 25264 | 18384 | 72.8% | 3685 | 3428 | 93.0% | 67.7% |
| DRC-3 | 6360 | 5831 | 91.7% | 20672 | 16552 | 80.1% | 2940 | 2719 | 92.5% | 74.1% |
| DRC-4 | 6353 | 4346 | 68.4% | 30951 | 13265 | 42.9% | 1369 | 1236 | 90.3% | 38.7% |
| Ethiopia-2 | 5090 | 3499 | 68.7% | 8005 | 8005 | 100.0% | 1949 | 1290 | 66.2% | 66.2% |
| Kenya-1 | 3121 | 151 | 4.8% | 742 | 147 | |||||
| Kenya-2 | 12780 | 2860 | 22.4% | 6274 | 3482 | 2246 | 64.5% | |||
| Lao rep | 2179 | 61 | 2.8% | 316 | 26 | |||||
| Nepal | 4338 | 6596 | 2708 | 2529 | 93.4% | |||||
| Nigeria | 2532 | 387 | 86 | 58 | 67.4% | |||||
| Pakistan-1 | 3608 | 3037 | 84.2% | 19191 | 3478 | 2160 | 62.1% | |||
| Pakistan-2 | 3230 | 481 | 14.9% | 3704 | 3111 | 84.0% | 316 | 43 | 13.6% | 11.4% |
| Uganda-2 | 2041 | 308 | 15.1% | 882 | 573 | 65.0% | 483 | 84.3% | 54.8%( | |
| Yemen | 2259 | 1030 | 45.6% | 5059 | 3200 | 63.3% | 1356 | 2093 | 65.4% | 41.4%( |
| Zimbabwe | 2346 | 1313 | 56.0% | 4899 | 210 | |||||
(*) all contacts were planned to be tested irrespective of symptoms
† CI = Contact investigation
‡ Eligible index cases are SS+ cases notified with exception of DRC(3x) and Pakistan-2 where also other forms of TB were considered as index case as index
Yield of active case finding and proportion of notified SS+ cases found through contact investigation (n = 18).
| SS+ cases notified in population | found through contact investigation | Index coverage | |||
|---|---|---|---|---|---|
| Project | Cases | Cases | % | (95% CI) | % |
| Afghanistan-1 | 2382 | 136 | 5.7% | (4.8–6.6%) | |
| Afghanistan-2 | 4777 | 210 | 4.4% | (3.8–5.0%) | 60.6% |
| DRC-1 | 2610 | 166 | 6.4% | (5.4–7.3%) | |
| DRC-2 | 5767 | 322 | 5.6% | (5.0–6.2%) | 66.9% |
| DRC-3 | 5145 | 300 | 5.8% | (5.2–6.5%) | 91.7% |
| DRC-4 | 4802 | 127 | 2.6% | (2.2–3.1%) | 68.4% |
| Ethiopia-1 | 687 | 11 | 1.6% | (0.7–2.5%) | |
| Ethiopia-2 | 5090 | 62 | 1.2% | (0.9–1.5%) | 68.7% |
| Kenya-1 | 3121 | 3 | 0.1% | (0.0–0.2%) | 4.8% |
| Kenya-2 | 12780 | 87 | 0.7% | (0.5–0.8%) | 22.4% |
| Lao rep | 2179 | 1 | 0.0% | (0.0–0.1%) | 2.8% |
| Nepal | 4338 | 68 | 1.6% | (1.2–1.9%) | |
| Nigeria | 2532 | 9 | 0.4% | (0.1–0.5%) | |
| Pakistan-1 | 3608 | 490 | 13.6% | (12.5–14.7%) | 84.2% |
| Pakistan-2 | 1292 | 4 | 0.3% | (0.0–0.6%) | 14.9% |
| Uganda-1 | 2041 | 287 | 14.1% | (12.6–15.6%) | 52.8% |
| Uganda-2 | 2259 | 32 | 1.4% | (0.9–1.9%) | 13.6% |
| Zimbabwe | 2346 | 60 | 2.6% | (1.9–3.2%) | 56.0% |
| Pooled estimate: | 1.8% | (0.9–3.5%) | |||